Meropenem pharmacokinetics and target attainment in critically ill patients
Y Gan, X Meng, N Lei, H Yu, Q Zeng… - Infection and Drug …, 2023 - Taylor & Francis
Purpose This study aimed to investigate the pharmacokinetics and target attainment of
meropenem and compare the effect of meropenem dosing regimens in critically ill patients …
meropenem and compare the effect of meropenem dosing regimens in critically ill patients …
In Vitro Activity of Polymyxin B in Combination with Various Antibiotics against Extensively Drug-Resistant Enterobacter cloacae with Decreased Susceptibility to …
Y Cai, TP Lim, J Teo, S Sasikala, W Lee… - Antimicrobial Agents …, 2016 - Am Soc Microbiol
Against extensively drug-resistant (XDR) Enterobacter cloacae, combination antibiotic
therapy may be the only option. We investigated the activity of various antibiotics in …
therapy may be the only option. We investigated the activity of various antibiotics in …
After standard dosage of piperacillin plasma concentrations of drug are subtherapeutic in burn patients
K Olbrisch, T Kisch, J Thern, E Kramme, J Rupp… - Naunyn-Schmiedeberg's …, 2019 - Springer
Infections are a major problem in patients with burn diseases. Mortality is high despite
antibiotic therapy as studies are controversial concerning drug underdosing. The aims of this …
antibiotic therapy as studies are controversial concerning drug underdosing. The aims of this …
Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use
TG Slama - Critical care, 2008 - Springer
Antipseudomonal carbapenems have played a useful role in our antimicrobial
armamentarium for 20 years. However, a review of their use during that period creates …
armamentarium for 20 years. However, a review of their use during that period creates …
Experimental verification of the efficacy of optimized two-step infusion therapy with meropenem using an in vitro pharmacodynamic model and Monte Carlo simulation
K Eguchi, K Kanazawa, T Shimizudani… - Journal of infection and …, 2010 - Elsevier
In this study we compared the efficacy of a theoretically optimized two-step infusion therapy
(OTIT; rapid first-step infusion and slow second-step infusion) to the efficacies of prolonged …
(OTIT; rapid first-step infusion and slow second-step infusion) to the efficacies of prolonged …
The pharmacokinetics and pharmacodynamics of the carbapenems: focus on doripenem
T Mazzei - Journal of Chemotherapy, 2010 - Taylor & Francis
Carbapenems are the most potent group of beta-lactam agents, having a broad spectrum of
bactericidal activity against both Gram-negative and Gram-positive bacteria including …
bactericidal activity against both Gram-negative and Gram-positive bacteria including …
Evaluating polymyxin B-based combinations against carbapenem-resistant Escherichia coli in time-kill studies and in a hollow-fiber infection model
Y Cai, TP Lim, JQM Teo, S Sasikala… - Antimicrobial Agents …, 2017 - Am Soc Microbiol
Polymyxin B-based combinations have emerged as a mainstay treatment against
carbapenem-resistant Escherichia coli (CREC). We investigated the activity of polymyxin B …
carbapenem-resistant Escherichia coli (CREC). We investigated the activity of polymyxin B …
From Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial …
Y Cai, NG Chua, TP Lim, JQM Teo, W Lee, A Kurup… - PLoS …, 2016 - journals.plos.org
Introduction Combination therapy is increasingly utilized against extensively-drug resistant
(XDR) Gram negative bacteria (GNB). However, choosing a combination can be problematic …
(XDR) Gram negative bacteria (GNB). However, choosing a combination can be problematic …
Pharmacokinetics of short versus extended infusion meropenem dosing in critically ill patients: a pilot study
Objective: To test whether a prolonged 3-hour infusion of meropenem 500mg achieves an
equivalent proportion of time above the minimal inhibitory concentration (MIC)(% T MIC) to …
equivalent proportion of time above the minimal inhibitory concentration (MIC)(% T MIC) to …